
By: Robert Connolly (Cartel Capers)
A somewhat obscure case was decided in early March by the Supreme Court, with implications that could, the author imagines, lead to substantial changes in Antitrust enforcement. In considering the circumstances of Bittner v. U.S., 598 U.S. __(2023), Justice Ketanji Brown Jackson joined Justice Neil Gorsuch’s opinion in a 5-4 decision regarding their interpretation of the Banking Secrecy act, and what constitutes a violation of it. Hingeing on the decision is far more than a $2 million fine for Bittner – The case caught this commentator’s eye because of Justice Jackson’s reasoning in favor of the defendant based on the rule of lenity.
The Rule of Lenity
Justice Brown joined Gorsuch’s ruling interpreting the Bank Secrecy Act in favor of the defendant, relying in part on the rule of lenity, which states: “the law is settled that penal statutes are to be construed strictly,”’ and an individual ‘“is not to be subjected to a penalty unless the words of the statute plainly impose it.”’ Bittner, slip opinion at 14, citing, Commissioner v. Acker, 361 U.S. 87, 91 (1959). As the text contained certain ambiguity regarding Bittner’s liability for unreported accounts, a reading of this rule would justify taking the more lenient definition in this controversy.
There have been many challenges to the use of the per se rule in criminal antitrust cases which to date have been beaten back by ample precedent in every circuit upholding the per se rule. But, if eventually the Supreme Court takes a per se rule challenge, could the rule of lenity help cement a majority to overturn the per se rule..?
Featured News
Meta Begins Defense After FTC Concludes Case in Landmark Antitrust Trial
May 15, 2025 by
CPI
UK Data Bill Still No Closer to Passage As Parliamentary ‘Ping-Pong’ Drags On
May 15, 2025 by
CPI
Regeneron Pharmaceuticals Awarded $271.2M in Damages Against Amgen
May 15, 2025 by
CPI
FTC Chair Proposes 15% Staff Reduction Amid Budget Constraints
May 15, 2025 by
CPI
UK Urges Antitrust Watchdog to Prioritize Growth and Clarity in Business Regulation
May 15, 2025 by
CPI
Antitrust Mix by CPI
Antitrust Chronicle® – Healthcare Antitrust
May 14, 2025 by
CPI
Healthcare & Antitrust: What to Expect in the New Trump Administration
May 14, 2025 by
Nana Wilberforce, John W O'Toole & Sarah Pugh
Patent Gaming and Disparagement: Commission Fines Teva For Improperly Protecting Its Blockbuster Medicine
May 14, 2025 by
Blaž Višnar, Boris Andrejaš, Apostolos Baltzopoulos, Rieke Kaup, Laura Nistor & Gianluca Vassallo
Strategic Alliances in the Pharma Sector: An EU Competition Law Perspective
May 14, 2025 by
Christian Ritz & Benedikt Weiss
Monopsony Power in the Hospital Labor Market
May 14, 2025 by
Kevin E. Pflum & Christian Salas